Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R. Kalra, Claes Christian Strom, John G.F. Cleland et al.|The Lancet|2022Cited by 367
Ultrasound imaging of congestion in heart failure: examinations beyond the heartPierpaolo Pellicori, Nicolas Girerd, Elke Platz et al.|European Journal of Heart Failure|2020Cited by 182
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trialJohn G.F. Cleland, Theis Lange, Muhammad Javed Khan et al.|European Heart Journal|2020Cited by 143
Prognostic value of the chest X-ray in patients hospitalised for heart failureDaniel Pan, Andrew L. Clark, Pierpaolo Pellicori et al.|Clinical Research in Cardiology|2021Cited by 25
Hospital admissions in the last year of life of patients with heart failureAlexandra Abel, Andrew L. Clark, Nathan Samuel et al.|European Heart Journal - Quality of Care and Clinical Outcomes|2023Cited by 8